SCHEMBL19906030

SCHEMBL19906030

Cc1cc2nc(-c3cccc4c3cnn4C)sc2c(-c2ccc(Cl)cc2)c1CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
KDR P35968 1/20 0.38
PDE5A O76074 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE7A Q13946 1/20 0.37
PDE1C Q14123 1/20 0.37
PDE3A Q14432 1/20 0.37
PTGDR2 Q9Y5Y4 5/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ABL1 P00519 1/20 0.35
FABP4 P15090 1/20 0.34
ABCB1 P08183 2/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19905978 0.86 PTGDR2 (0.40) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906180 0.85 PTGDR2 (0.41) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19905803 0.85 KDM4E (0.39) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906170 0.85 KDM4E (0.41) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL17547120 0.85 KDM4E (0.37) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906057 0.84 PTGDR2 (0.37) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906010 0.84 KDM4E (0.36) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906146 0.83 PTGDR2 (0.36) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19905884 0.83 KDM4E (0.38) KDM4EPDE5APDE1APDE1BPDE4D
SCHEMBL19906048 0.82 PTGDR2 (0.38) KDM4EPDE5APDE1APDE1BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070081-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2018-02-28 EP disclosed